MORGAN HURTA: Open Payments
NPI 1417663808 · NEW BRAUNFELS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$901 in 43 payments from 12 companies in 2025. Trend: 2023 $503 · 2024 $410 · 2025 $901
Food & beverage: $901
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $266 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $158 |
| Sumitomo Pharma America, Inc. | 5 | $131 |
| Biogen, Inc. | 6 | $131 |
| Exeltis, USA Inc. | 5 | $76 |
| Organon LLC | 2 | $27 |
| CooperSurgical, Inc. | 1 | $26 |
| Boston Scientific Corporation | 1 | $21 |
| MILLICENT US INC | 1 | $20 |
| Astellas Pharma US Inc | 1 | $19 |
Products named: BOTOX, GEMTESA, ZURZUVAE, SLYND, NEXPLANON, Paragard T 380A, Axonics, FEMRING.
Industry payments across TX — which companies pay providers there.
